Failure to predict hemolysis and hyperbilirubinemia by IgG subclass in blood group A or B infants born to group O mothers

Pediatrics

Volumn 123, Issue 1, 2009, Pages

  Kaplan, Michael ^a,b,c   Na'Amad, Mira ^b   Kenan, Aner ^c   Rudensky, Bernard ^b   Hammerman, Cathy ^a,c   Vreman, Hendrik J ^d   Wong, Ronald J ^d   Stevenson, David K ^d  

^a Department of Neonatology ^*  (Israel)

^b SHAARE ZEDEK MEDICAL CENTER   (Israel)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Abo heterospecificity; Bilirubin; Blood groups; Carboxyhemoglobin; Direct antibody titer; Gel technology; Hemolysis; Hyperbilirubinemia; Prediction

Indexed keywords

BILIRUBIN; CARBON MONOXIDE; CARBOXYHEMOGLOBIN; HEMOGLOBIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; DIAGNOSTIC AGENT; IMMUNOGLOBULIN G;

ANTIBODY TITER; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD GROUP A; BLOOD GROUP B; BLOOD GROUP INCOMPATIBILITY; BLOOD GROUP O; CATABOLISM; CONTROLLED STUDY; FEMALE; HEME CATABOLISM; HEMOLYSIS; HOSPITAL DISCHARGE; HUMAN; HYPERBILIRUBINEMIA; INFANT; MAJOR CLINICAL STUDY; MALE; MOTHER; NEWBORN; PHOTOTHERAPY; PRIORITY JOURNAL; UMBILICAL CORD BLOOD; BLOOD; BLOOD GROUP ABO SYSTEM; CLASSIFICATION; COMPARATIVE STUDY; NEWBORN JAUNDICE; PHYSIOLOGY; PREDICTION AND FORECASTING; PREGNANCY; RISK FACTOR; TREATMENT FAILURE;

ABO BLOOD-GROUP SYSTEM; BILIRUBIN; BLOOD GROUP INCOMPATIBILITY; FEMALE; HEMOLYSIS; HUMANS; HYPERBILIRUBINEMIA; IMMUNOGLOBULIN G; INFANT, NEWBORN; JAUNDICE, NEONATAL; MALE; PREDICTIVE VALUE OF TESTS; PREGNANCY; RISK FACTORS; TREATMENT FAILURE;

EID: 59449106426     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2008-2617     Document Type: Article

References (23)

1. Grundbacher FJ. The etiology of ABO hemolytic disease of the newborn. Transfusion. 1980;20(5):563-568
2. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation [published correction appears in Pediatrics. 2004;114(4):1138]. Pediatrics. 2004; 114(1):297-316
3. Ozolek JA, Watchko JF, Mimouni F. Prevalence and lack of clinical significance of blood group incompatibility in mothers with blood type A or B. J Pediatr. 1994;125(1):87-91
4. Meberg A, Johansen KB. Screening for neonatal hyperbilirubinaemia and ABO alloimmunization at the time of testing for phenylketonuria and congenital hypothyreosis. Acta Paediatr. 1998;87(12):1269-1274
5. Ukita M, Takahashi A, Nunotani T, Kihana T, Watanabe S, Yamada N. IgG subclasses of anti-A and anti-B antibodies bound to the cord red cells in ABO incompatible pregnancies. Vox Sang. 1989;56(3):181-186
6. Brecher ME. Immunology. In: Brecher ME, ed. Technical Manual. Bethesda, MD: American Association of Blood Banks; 2005:258 -269
7. Mackenzie SB. Hemolytic anemia due to extrinsic factors. In: Textbook of Hematology. Baltimore, MD: Williams & Wilkins; 1996:245-274
8. Pollock JM, Bowman JM. Anti-Rh(D) IgG subclasses and severity of Rh hemolytic disease of the newborn. Vox Sang. 1990; 59(3):176-179
9. Thomas NC, Shirey RS, Blakemore K, Kickler TS. A quantitative assay for subclassing IgG alloantibodies implicated in hemolytic disease of the newborn. Vox Sang. 1995;69(2):120-125
10. Vreman HJ, Mahoney JJ, Stevenson DK. Carbon monoxide and carboxyhemoglobin. Adv Pediatr. 1995;42:303-334
11. Kaplan M, Bromiker R, Schimmel MS, Algur N, Hammerman C. Evaluation of discharge management in the prediction of hyperbilirubinemia: the Jerusalem experience. J Pediatr. 2007;150(4):412-417
12. Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics. 1999;103(1):6-14
13. Alden ER, Lynch SR, Wennberg RP. Carboxyhemoglobin determination in evaluating neonatal jaundice. Am J Dis Child. 1974;127(2):214-217
14. Vreman HJ, Kwong LK, Stevenson DK. Carbon monoxide in blood: an improved microliter blood-sample collection system with rapid analysis by gas chromatography. Clin Chem. 1984; 30(8):1382-1386
15. Vreman HJ, Stevenson DK, Zwart A. Analysis for carboxyhemoglobin by gas chromatography and multicomponent spectrophotometry compared. Clin Chem. 1987;33(5):694-697
16. Ostrander CR, Cohen RS, Hopper AO, Cowan BE, Stevens GB, Stevenson DK. Paired determinations of blood carboxyhemoglobin concentration and carbon monoxide excretion rate in term and preterm infants. J Lab Clin Med. 1982;100(5):745-755
17. Lynen R, Krone O, Legler TJ, Köhler M, Mayr WR. A newly developed gel centrifugation test for quantification of RBC- bound IgG antibodies and their subclasses IgGl and IgG3: comparison with flow cytometry. Transfusion. 2002;42(5): 612-618
18. Kaplan M, Muraca M, Hammerman C, et al. Imbalance between production and conjugation of bilirubin: a fundamental concept in the mechanism of neonatal jaundice. Pediatrics. 2002;110(4). Available at: www.pediatrics.org/cgi/ content/ full/110/4/e47
19. Sgro M, Campbell D, Shah V. Incidence and causes of severe neonatal hyperbilirubinemia in Canada. CMAJ. 2006;175(6):587-590
20. Salas AA, Mazzi E. Exchange transfusion in infants with extreme hyperbilirubinemia: an experience from a developing country. Acta Paediatr. 2008;97(6):754-758
21. Ramasethu J, Luban NL. Alloimmune hemolytic disease of the newborn; In: Lichtman MA, Kipps TJ, Seligsohn U, Kaushansky K, Prchal JT, eds. William's Hematology. New York, NY: McGraw-Hill Medical Publishing Division; 2006:751-765
22. Blanchette V, Dror Y, Chan A. Hematology. In: MacDonald MG, Mullett MD, Seschia MM, eds. Avery's Neonatology: Pathophysiology and Management of the Newborn. Philadelphia, PA: Lippincott Williams & Wilkins; 2005:1169-1234
23. Stevenson DK, Fanaroff AA, Maisels MJ, et al. Prediction of hyperbilirubinemia in near-term and term infants. Pediatrics. 2001;108(1):31-39